Zobrazeno 1 - 10
of 78
pro vyhledávání: '"H.C. Geiss"'
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 8, Pp 1459-1467 (2004)
LDL can be subfractionated into buoyant (1.020–1.029 g/ml−1), intermediate (1.030–1.040 g/ml−1), and dense (1.041–1.066 g/ml−1) LDLs. We studied the rebound of these LDL-subfractions after LDL apheresis in seven patients with heterozygous
Externí odkaz:
https://doaj.org/article/6c8267f826d3449fac03f332a5c55517
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 5, Pp 727-733 (2000)
Epidemiologic studies and in vitro experiments indicate that low density lipoprotein (LDL) subtypes differ concerning their atherogenic potential. Small, dense LDL are more atherogenic than large, buoyant LDL. LDL apheresis is a potent therapeutic mo
Externí odkaz:
https://doaj.org/article/34fd9ede620c4218a5c94236f30cf9bd
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 113:49-52
INTRODUCTION Patients with diabetes mellitus type 2 are characterized by a typical dyslipoproteinemia. Improvement in glucose control usually also ameliorates this dyslipoproteinemia. It is unclear whether different antidiabetic strategies differ in
Publikováno v:
Metabolism. 50:983-988
Atorvastatin is a potent hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor that decreases low-density lipoprotein (LDL) cholesterol and triglyceride concentrations, but little is known about its effects on LDL subtype distribution in d
Publikováno v:
International Journal of Obesity. 25:830-837
To investigate which of the currently applied parameters to assess childhood overweight best predict cardiovascular risk factors.Cross-sectional study comparing five different methods to define overweight with respect to their power to predict cardio
Publikováno v:
International Journal of Obesity. 25:S89-S92
OBJECTIVE: We describe the design and baseline data of the Prevention Education Program (PEP), a home-based and family oriented intervention program, aimed to assess and improve cardiovascular risk factors in school children and their families during
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 5, Pp 727-733 (2000)
Epidemiologic studies and in vitro experiments indicate that low density lipoprotein (LDL) subtypes differ concerning their atherogenic potential. Small, dense LDL are more atherogenic than large, buoyant LDL. LDL apheresis is a potent therapeutic mo
Publikováno v:
Journal of Internal Medicine. 245:47-55
Objectives. Atorvastatin is a new potent HMG-CoA reductase inhibitor. We evaluated whether patients with coronary heart disease and severe hypercholesterolaemia showing insufficient LDL (low-density lipoprotein) cholesterol reduction despite combined
Autor:
Cecilia Giunta, H.C. Geiss, Andrea Superti-Furga, E. Laubach, Beat Steinmann, E. Hiller, Michael M. Ritter, Peter Schwandt
Publikováno v:
Der Internist. 38:1225-1230
Aufgrund des klinischen Bildes einer familiaren Blutungsneigung sowie mehrerer Komplikationen (spontane A. carotis-Sinus cavernosus-Fistel, Arteriendissektion bei einer Angiographie, Nierenarterienaneurysmata, spontane Peritoneumeinrisse) wurde bei d